Raptiva is also markets since November 2003 is available in the U.S., where there are Genentech for the treatment of moderate to severe chronic plaque psoriasis in adults aged 18 or older who are candidates for systemic therapy or phototherapy.. Serono received authorization for Raptiva in Switzerland in March and in Argentina in the past month and is awaiting the results of the marketing applications in a number of other areas, for which he is responsible.
The conference call will also be via live audio webcast, which interested parties about access Serono Corporate home page can be redirected to a link to the webcast direct prior to the event and will be be available as a recording after the event.
In 2003, Serono achieved worldwide revenues of U.S. $ 2.6 million and a net income of U.S. $ 390, making it the third largest biotech company in the world. Its products are sold in over 90 countries. Bearer shares of Serono SA, the holding company, are traded on the virt-x and its American Depositary Shares on the New York are traded traded .The patient group the cause for unaccountable breast pain.
Every year, many people seek emergency treatment of for unexplainable pain in the chest. A hypothesis on at the Sahlgrenska Academy, University of Gothenburg presents, Swedes, some common factors those affected, including stress at work, depression and a sedentary life style. Title of the thesis: Unexplainable pain in the chest both men and women – symptoms awareness and the result.
Opponent? Professor Anders Waldenstr m, University.